Simons Foundation: Genomics of ASD: Pathways to Genetic Therapies (SFARI)

 intended to advance our understanding of the genetic basis of ASD and the molecular and cellular consequences of genetic risk, and to provide a foundation for the development of treatments for select genetically defined forms of the condition. Special emphasis is placed on the use of scalable methods, especially as applied to genes that are suitable targets for genetic therapies.
Funding: between $200,000 and $400,000 for 2-3 years.

Please contact the research authority before submitting – Nonprofit.

https://www.sfari.org/grant/2021-genomics-of-asd-pathways-to-genetic-therapies-request-for-applications/